POSTMARKETING SURVEILLANCE IN SPAIN

被引：0

作者：

CAPELLA, D

CABEZA, L

VIDAL, X

IBANEZ, L

LAPORTE, JR

机构：

[1] UNIV AUTONOMA BARCELONA,DIV CLIN PHARMACOL,BELLATERRA BARCELONA,SPAIN

[2] CIUDAD SANITARIA VALLE HEBRON,SERV FARMACOL CLIN,BARCELLONA,SPAIN

来源：

ACTA PHARMACOLOGICA ET TOXICOLOGICA | 1986年 / 59卷

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：158 / 158

页数：1

共 50 条

[1] POSTMARKETING SURVEILLANCE
VOSS, S
HARRIS, F
[J]. BRITISH MEDICAL JOURNAL, 1994, 309 (6948): : 194 - 194
[2] POSTMARKETING SURVEILLANCE
DENES, G
[J]. MUNCHENER MEDIZINISCHE WOCHENSCHRIFT, 1990, 132 (23): : 373 - 375
[3] Postmarketing surveillance is needed
Srinivas, VR
[J]. BMJ-BRITISH MEDICAL JOURNAL, 2004, 329 (7456): : 51 - 51
[4] THE RATIONALE FOR A POSTMARKETING SURVEILLANCE
WESTERHOLM, B
[J]. HUMAN REPRODUCTION, 1987, 2 (01) : 41 - 44
[5] POSTMARKETING DRUG SURVEILLANCE
FELDMANN, EG
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (12) : R1 - R1
[6] POSTMARKETING SURVEILLANCE STUDIES
FLETCHER, AP
[J]. BRITISH MEDICAL JOURNAL, 1992, 305 (6847): : 257 - 257
[7] Postmarketing surveillance of gabapentin
[J]. Reactions Weekly, 2002, 926 (1) : 5 - 5
[8] THE DEMISE OF POSTMARKETING SURVEILLANCE
FLETCHER, AP
[J]. ADVERSE DRUG REACTIONS AND TOXICOLOGICAL REVIEWS, 1995, 14 (01): : 7 - 9
[9] POSTMARKETING DRUG SURVEILLANCE
BORDEN, EK
GARDNER, JS
WESTLAND, MM
GARDNER, SD
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1984, 251 (06): : 729 - 729
[10] POSTMARKETING SURVEILLANCE OF ENALAPRIL
ROSE, AJ
[J]. JOURNAL OF THE ROYAL COLLEGE OF GENERAL PRACTITIONERS, 1987, 37 (304): : 514 - 514